Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 33 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Neuronal surface autoantibodies at cerebellar and brainstem synapses: mechanisms, phenotypes, and translational gaps

4 affiliations
  1. 1Department of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital
  2. 2Department of Neurosurgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital
  3. 3Division of Colorectal Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital
  4. 4Yuncheng Central Hospital, Shanxi Medical University

Abstract

Pathogenic neuronal-surface autoantibodies can disrupt extracellular receptors, ion-channel complexes, and synaptic proteins, yet their regional neurological phenotypes differ substantially. This variability is particularly informative in the cerebellum and brainstem, where precisely timed excitatory and inhibitory signaling supports motor coordination, ocular-motor control, autonomic regulation, arousal, and respiration. In this Mini Review, we examine how antibody effector mechanisms, regional antigen distribution, and local synaptic physiology interact to shape cerebellar and brainstem manifestations of neuronal-surface-antibody disease. Autoimmunity against metabotropic glutamate receptor 1 (mGluR1) provides a model of cerebellar synaptic dysfunction because mGluR1 is strongly linked to Purkinje-cell signaling and synaptic plasticity, whereas glycine receptor (GlyR) autoimmunity illustrates how impaired inhibitory transmission can destabilize brainstem and spinal networks. NMDAR, AMPAR, GABA_A receptor, GABA_B receptor, LGI1, and CASPR2 autoimmunity provide mechanistic comparators showing that extracellular antigen accessibility alone does not determine neurological phenotype. Direct antibody-mediated synaptic dysfunction may be reversible, but persistent structural injury occurs in a subset of patients; current evidence does not determine whether such injury is attributable to sustained antibody exposure, accompanying T-cell inflammation, or both. Evidence from acute physiological experiments, individual follow-up cases, and heterogeneous cohorts comes from different settings and does not establish a uniform progression from synaptic dysfunction to atrophy.

Related

  1. Time-course profiling of behavioral phenotypes and Ywhah/ERK signaling expression within the vestibular region of the brainstem during motion sickness habituation
    Xue Yue, Chenxi Jia, Lihong Zhai +3
    Frontiers in NeurosciencePeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC
  2. Novel Autoantibodies in Rheumatoid Arthritis: Translational Prospects from Seronegative Breakthrough to Precision Diagnosis and Treatment.
    Zewen Wu, Huijing Zhang, Jiapeng Zhang +4
    InflammationPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  3. Sepsis-associated endothelial dysfunction: clinical phenotypes, biomarkers, bedside evidence, and translational implications
    Song Qin, Ninan Dai, Fengyun Xu +2
    The Journal of clinical investigationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  5. Physiological Basis of Skeletal Muscle Electrical Stimulation in Heart Failure with Reduced Ejection Fraction: Established Mechanisms, Extrapolated Mechanisms and Translational Priorities
    Damian Sendrowski, Dariusz Kozłowski
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{li2026neuronal,
  title = {{Neuronal surface autoantibodies at cerebellar and brainstem synapses: mechanisms, phenotypes, and translational gaps}},
  author = {Yan Li and Wenyuan Li and Zhaoben Zhang and Yuyuan Hu and Xinyu Ma and Zhijun Wang and Wei Zhang and Yanhong Wang},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1962978},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1962978/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Neuronal surface autoantibodies at cerebellar and brainstem synapses: mechanisms, phenotypes, and translational gaps
AU  - Yan Li
AU  - Wenyuan Li
AU  - Zhaoben Zhang
AU  - Yuyuan Hu
AU  - Xinyu Ma
AU  - Zhijun Wang
AU  - Wei Zhang
AU  - Yanhong Wang
PY  - 2026
DA  - 2026/10/07
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1962978
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1962978/full
AB  - Pathogenic neuronal-surface autoantibodies can disrupt extracellular receptors, ion-channel complexes, and synaptic proteins, yet their regional neurological phenotypes differ substantially. This variability is particularly informative in the cerebellum and brainstem, where precisely timed excitatory and inhibitory signaling supports motor coordination, ocular-motor control, autonomic regulation, arousal, and respiration. In this Mini Review, we examine how antibody effector mechanisms, regional antigen distribution, and local synaptic physiology interact to shape cerebellar and brainstem manifestations of neuronal-surface-antibody disease. Autoimmunity against metabotropic glutamate receptor 1 (mGluR1) provides a model of cerebellar synaptic dysfunction because mGluR1 is strongly linked to Purkinje-cell signaling and synaptic plasticity, whereas glycine receptor (GlyR) autoimmunity illustrates how impaired inhibitory transmission can destabilize brainstem and spinal networks. NMDAR, AMPAR, GABA_A receptor, GABA_B receptor, LGI1, and CASPR2 autoimmunity provide mechanistic comparators showing that extracellular antigen accessibility alone does not determine neurological phenotype. Direct antibody-mediated synaptic dysfunction may be reversible, but persistent structural injury occurs in a subset of patients; current evidence does not determine whether such injury is attributable to sustained antibody exposure, accompanying T-cell inflammation, or both. Evidence from acute physiological experiments, individual follow-up cases, and heterogeneous cohorts comes from different settings and does not establish a uniform progression from synaptic dysfunction to atrophy.
SN  - 1664-3224
ER  -